Tiffany Li
5PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 22, 2025
What you measure matters: the importance of outcome measures in evaluating the prevalence of painful chemotherapy-induced peripheral neuropathy.Tiffany Li, David Goldstein, Susanna B Park
|May 01, 2024
Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.Nicole Yeung, Tiffany Li, Hui-Ming Lin
|Jan 20, 2024
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paper.Paola Alberti, Andreas A Argyriou, Jordi Bruna
|May 21, 2022
Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use.Tiffany Li, Susanna B Park, Eva Battaglini
|Dec 25, 2019
Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials.Tiffany Li, Hannah C Timmins, Tracy King
Pageof 1
Frequent Collaborators
3 joint publications
Susanna B Park
1 joint publications
Paola Alberti
1 joint publications
Andreas A Argyriou
1 joint publications
Jordi Bruna
1 joint publications
Sara Faithfull
1 joint publications
Ahmet Hoke
1 joint publications
Robert Knoerl
1 joint publications
Noah Kolb
1 joint publications
Nathan P Staff
1 joint publications
Stefano Tamburin
